Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jiuwei Zhenxin granules versus duloxetine in generalized anxiety disorder with multimodal psychiatric imaging
ChiCTR2400087090Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jul 2024
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of jiuwei zhenxin in generalized anxiety disorder (GAD) (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Functional connectivity strength, Amplitude of low frequency fluctuation and 1 more. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
jiuwei zhenxin
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on ChiCTR2400087090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400087090.